Physiological aspects of cardiac tissue engineering
- 15 July 2012
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 303 (2) , H133-H143
Abstract
Cardiac tissue engineering aims at repairing the diseased heart and developing cardiac tissues for basic research and predictive toxicology applications. Since the first description of engineered heart tissue 15 years ago, major development steps were directed toward these three goals. Technical innovations led to improved three-dimensional cardiac tissue structure and near physiological contractile force development. Automation and standardization allow medium throughput screening. Larger constructs composed of many small engineered heart tissues or stacked cell sheet tissues were tested for cardiac repair and were associated with functional improvements in rats. Whether these approaches can be simply transferred to larger animals or the human patients remains to be tested. The availability of an unrestricted human cardiac myocyte cell source from human embryonic stem cells or human-induced pluripotent stem cells is a major breakthrough. This review summarizes current tissue engineering techniques with their strengths and limitations and possible future applications.Keywords
This publication has 109 references indexed in Scilit:
- Pluripotent stem cell-derived cardiac tissue patch with advanced structure and functionBiomaterials, 2011
- Somatic coding mutations in human induced pluripotent stem cellsNature, 2011
- Modulation of human embryonic stem cell-derived cardiomyocyte growth: A testbed for studying human cardiac hypertrophy?Journal of Molecular and Cellular Cardiology, 2011
- Scaffold-free vascular tissue engineering using bioprintingBiomaterials, 2009
- LG4–5 domains of laminin‐211 binds α‐Dystroglycan to allow myotube attachment and prevent anoikisJournal of Cellular Physiology, 2009
- Death and Proliferation Time Course of Stem Cells Transplanted in the MyocardiumMolecular Imaging and Biology, 2009
- Pre‐treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissueJournal of Biomedical Materials Research Part A, 2007
- Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injuryNature Medicine, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine, 2006